An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging

PHASE3CompletedINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

May 11, 2014

Primary Completion Date

April 9, 2015

Study Completion Date

April 9, 2015

Conditions
Liver Lesions
Interventions
DRUG

Sonazoid™

Single Dose of Sonazoid™ 0.12 µL MB/kg as I.V. injection.

DRUG

SonoVue®

Single Dose of SonoVue® 2.4 mL as I.V. injection.

Trial Locations (18)

100

National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei

112

Taipei Veterans General Hospital, No. 201 Shih-Pai Road, Sec. 2, Taipei

10449

Mackay Memorial Hospital, No. 92, Sec. 2 Zhongshan N. Road, Taipei

10650

Cathay General Hospital, No. 280 Jen-Ai Road, Sec. 4, Taipei

100032

Peking Union Medical College Hospital, West Campus: No. 41 Damucang Hutong, Xicheng

100730

Peking Union Medical College Hospital, East Campus: No.1 Shuaifuyuan Wangfujing, Dongcheng

100853

Chinese PLA General Hospital, No. 28 Fuxing Road, Haidan

200032

Zhongshan Hospital Fudan University, No. 180 Fenglin Road, Xuhui

200040

Shanghai Hua Shan Hospital, No. 12 Wulumuqi Middle Road, Xuhui

200072

Shanghai Tenth People's Hospital, No. 301 Yanchang Middle Road, Zhabei

200080

Shanghai First Hospital, North Campus: No. 100 Haining Road, Hongkou

200233

Shanghai Sixth Hospital, No. 600 Yishan Road, Xuhui

201620

Shanghai First Hospital, South Campus: No.650 New Songjiang Road, Songjiang

510080

The First Affiliated Hospital, Sun-Yat sen University, No. 58 Zhongshan Second Road, Guangzhou

510120

The Second Affiliated Hospital of Zhongshan University, No. 107 Yanjiang West Road, Guangzhou

110-744

Seoul National University Hospital, 101, Daehak-Ro, Jongno-Gu, Seoul

137-701

Seoul St Mary's Hospital, 222 Banpo-daero, Seocho-gu, Seoul

Unknown

National Taiwan University Hospital - Yunlin Branch, No. 579, Sec. 2 Yunlin Road, Douliu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GE Healthcare

INDUSTRY

NCT03335566 - An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging | Biotech Hunter | Biotech Hunter